Triple-Negative Breast Cancer (TNBC) is called “triple negative” because there are three specific kinds of receptors that were not found when your tumor was tested. The tumor has no receptors for estrogen, progesterone, or HER2. This brief animated video provides an overview of TNBC and the types of therapy that may be used to treat it.
Please talk with your doctor and see the NCCN Guidelines for Patients: Invasive Breast Cancer and the NCCN Guidelines for Patients: Metastatic Breast Cancer for more information. [ Ссылка ]
This video is for informational purposes only and is not intended to be a substitute for medical advice. Talk with your doctor to determine the right course of treatment for you.
Supporters:
This video is presented with support from the NCCN Foundation and by contributions from the corporate supporter of this video, Pfizer Inc.
NCCN Guidelines for Patients are developed independently and corporate supporters do not participate in their development.
________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit www.nccn.org/patients/foundation
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit [ Ссылка ] for more information.
Subscribe to our channel for the latest in cancer care: [ Ссылка ]
Connect with us!
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
